ArticleACS medicinal chemistry letters2022

Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes.

Anandan Palani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.